Fresenius SE & Co. KGaA (FSNUY)
OTCMKTS · Delayed Price · Currency is USD
12.77
+0.40 (3.26%)
Aug 8, 2025, 3:58 PM EDT
Allakos Market Cap
Fresenius SE & Co. KGaA has a market cap or net worth of $28.74 billion as of August 8, 2025. Its market cap has increased by 48.31% in one year.
Market Cap
28.74B
Enterprise Value
43.07B
Revenue
26.14B
Ranking
n/a
PE Ratio
21.75
Stock Price
$12.77
Market Cap Chart
Since April 23, 1997, Fresenius SE & Co. KGaA's market cap has increased from 2.17B to 28.74B, an increase of 1,224.44%. That is a compound annual growth rate of 9.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 28.74B | 46.63% |
| Dec 30, 2024 | 19.60B | 12.16% |
| Dec 29, 2023 | 17.48B | 10.60% |
| Dec 30, 2022 | 15.80B | -29.41% |
| Dec 30, 2021 | 22.38B | -13.65% |
| Dec 30, 2020 | 25.92B | -17.36% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 575.48M |
| Glass House Brands | 494.36M |
| Northwest Biotherapeutics | 366.60M |
| American Oncology Network | 330.70M |
| CytoDyn | 328.46M |